BIOMARKERS PREDICTIVE OF PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS AND USES THEREOF

摘要

Methods, assays and kits for the identification, assessment and/or treatment of a subject having multiple sclerosis (MS) (e.g., a patient with primary progressive multiple sclerosis (PPMS)) are disclosed.